Clinical trial
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing…
NCT00080873 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00080873 |
|---|---|
| Title | Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation |
| Official title | A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Kidney Cancer, Leukemia, Lymphoma, Neuroblastoma, Oral Complications, Sarcoma |
| Intervention type | Drug, Other |
| Interventions | Traumeel S, Placebo |
| Enrollment | 195 |
| Start date | Apr 1, 2004 |
| Primary completion | Nov 1, 2006 |
| Completion | Jan 1, 2011 |
| First posted | Apr 8, 2004 |
| Last update posted | Jan 7, 2016 |
| Countries | Australia, Canada, Israel, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: